Neupro phase 3
Showing 1 - 25 of >10,000
Substance-Related Disorders Trial in Richmond (Rotigotine Transdermal System [Neupro], Placebo)
Not yet recruiting
- Substance-Related Disorders
- Rotigotine Transdermal System [Neupro]
- Placebo
-
Richmond, VirginiaVirginia Commonwealth University
Jun 1, 2023
Familial Chylomicronemia Syndrome Trial (VSA001 injection, Placebo)
Not yet recruiting
- Familial Chylomicronemia Syndrome
- VSA001 injection
- Placebo
- (no location specified)
Jun 9, 2023
Glioblastoma Multiforme, Adult Trial (Adaptive, two-phase RT)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Adaptive, two-phase RT
- (no location specified)
Feb 8, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
Essential Tremor Trial (60 mg ulixacaltamide, Placebo)
Not yet recruiting
- Essential Tremor
- 60 mg ulixacaltamide
- Placebo
- (no location specified)
Oct 12, 2023
Myocardial Infarction Trial (other, diagnostic test, device)
Not yet recruiting
- Myocardial Infarction
- Therapeutic educational consolidation program in Phase 3 of cardiac rehabilitation associating a patient & caregiver partnership
- +8 more
- (no location specified)
Jun 30, 2023
Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- IHL-42X Low Dose
- +5 more
- (no location specified)
Nov 22, 2023
CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic
Recruiting
- CIN3
- +3 more
- Vvax001 therapeutic cancer vaccine
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)
Not yet recruiting
- Rheumatoid Arthritis
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 25, 2023
Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)
Not yet recruiting
- Prostate Cancer
- [99mTc]Tc-PSMA-T4
- (no location specified)
Apr 26, 2023
Myopia Trial in Wenzhou (QLM3004 Concentration 1, QLM3004 Concentration 2, QLM3004 Concentration 3)
Recruiting
- Myopia
- QLM3004 Concentration 1
- +3 more
-
Wenzhou, Zhejiang, ChinaThe Affiliated Eye Hospital of Wenzhou Medical University
Nov 21, 2023
COVID-19 Pneumonia, COVID-19 Respiratory Infection Trial in India (Ramatroban, Placebo)
Recruiting
- COVID-19 Pneumonia
- COVID-19 Respiratory Infection
- Ramatroban
- Placebo
-
Nellore, Andhra Pradesh, India
- +6 more
Jan 28, 2023
Covid19 Trial in South Miami (Convalescent Plasma, Standard of Care)
Withdrawn
- Covid19
- Convalescent Plasma
- Standard of Care
-
South Miami, FloridaLarkin Community Hospital
Oct 12, 2023
Bowel Preparation Trial in Seoul (CTP0301-A, CTP0301-B, Cool prep)
Recruiting
- Bowel Preparation
- CTP0301-A
- +2 more
-
Seoul, Korea, Republic ofTaejoon Pharmaceutical Co., Ltd.
May 21, 2023
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
Presbyopia, Refractive Error, Near Vision Trial in Glendale (Aceclidine + Brimonidine, Aceclidine, Brimonidine)
Recruiting
- Presbyopia
- +4 more
- Aceclidine + Brimonidine
- +2 more
-
Glendale, CaliforniaSite #101
Jan 10, 2023
Presbyopia, Near Vision, Miosis Trial in Newport Beach (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine,
Not yet recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Newport Beach, CaliforniaSite #201
Feb 6, 2023
